1Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California San Francisco, San Francisco, California
2French Clinical Research Infrastructure Network, Investigation Network Initiative Cardiovascular and Renal Trialists, Nancy, France
3Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
4Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois
5Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
6Department of Anesthesiology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan
7AM-Pharma, Utrecht, The Netherlands
8Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York
9The George Institute for Global Health, University of New South Wales, Sydney, Australia
10Département de Réanimation, Medical and surgical intensive care unit, Assistance Publique-Hôpitaux de Paris Hôpital Avicenne, Bobigny, France
11Common and Rare Kidney Diseases, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1155, Paris, France
12Divisions of Nephrology and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, California
13Department of Medicine, University of California San Diego, San Diego, California
14Department of Anesthesia and Perioperative Medicine, University of California San Francisco, San Francisco, California
15Division of Chronic Care Management, Chronic Care Policy Group, Center for Medicare, Center for Medicare and Medicaid Services, Baltimore, Maryland
16Boehringer Ingelheim International GmbH, Ingelheim, Germany
17Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
18Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
19Vifor Pharma AG, Zurich, Switzerland
20Department of Anesthesiology, Lerner College of Medicine of Case Western University, Cleveland, Ohio
21Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio
22Section of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
23Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany
24Division of Allergy, Pulmonary, and Critical Care, Vanderbilt University Medical Center, Nashville, Tennessee
25University of Lorraine, INSERM CIC 1433, Nancy, France
26Nancy CHRU, INSERM U1116, Nancy, French national institute of Health and Medical Research, unit 1116, Nancy, France
27Clinical Trials Methods and Outcomes Laboratory, PAIR (Palliative and Advanced Illness Research) Center, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence: Dr. Matthieu Legrand, Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143. Email: [email protected]
